Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Sanwa Kagaku’s SHPT Drug Meets Primary Goal in Japan PIII
October 26, 2020
- Cyberattacks Leak Data from Shionogi’s Taiwan Subsidiary
October 26, 2020
- Novartis Looks to Solidify Presence in Multiple Sclerosis Arena with Mayzent, then Ofatumumab
October 23, 2020
- Chugai Enjoys Higher Earnings in January-September on Hemlibra
October 23, 2020
- Fujifilm Taps Carelink as Chinese Partner for Avigan
October 23, 2020
- Daiichi Sankyo Kicks Off PI Study for I/O Therapy DS-1055
October 23, 2020
- AstraZeneca’s Japan COVID-19 Vaccine Trial Ongoing after Death Reported in Brazil
October 23, 2020
- Kyowa Kirin Delivers Positive PIIb Data for Parkinson’s Med KW-6356
October 22, 2020
- Aducanumab Filed in Europe: Biogen/Eisai
October 22, 2020
- Chugai Licenses Antibody Engineering Tech to Novo
October 22, 2020
- GSK Sets Up Oncology Biz Unit in Japan; Multiple Late-Stage Assets in Pipeline
October 22, 2020
- Pfizer, BioNTech Begin Japan PI/II Study for COVID-19 Vaccine
October 21, 2020
- Drug Promotions Collectively Down in August: Intage
October 21, 2020
- Astellas Wins FDA’s Fast-Track Tag for Primary Mitochondrial Myopathies Drug
October 21, 2020
- Sawai to Launch Zagallo Generic on Nov. 6
October 20, 2020
- Pfizer Starts Promotion for 4 Authorized Generics, Including Lyrica AG
October 20, 2020
- LEO Pharma’s Atopic Dermatitis Program Lags as PMDA Requests Japanese Data, but Growth Goal Intact
October 20, 2020
- Fujifilm Eyes Avigan Use in Mild and Severe COVID-19 Cases: Exec
October 19, 2020
- Chinese Regulators Accept Eisai’s Fycompa for Monotherapy, Additional Pediatric Use
October 19, 2020
- (Update) Avigan Filed for COVID-19 in Japan: Fujifilm
October 16, 2020
